+255.3%
MRVL vs CVS
+32.3%
+223.0%
-48.3%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | CVS | Excess | Alpha |
|---|---|---|---|---|
| 1D | +4.0% | -0.7% | +4.7% | +3.9% |
| 7D | +5.6% | -2.2% | +7.8% | +5.3% |
| 30D | +8.8% | -0.1% | +8.8% | +8.8% |
| 3M | -15.9% | -5.2% | -10.7% | -16.1% |
| 6M | +161.3% | +26.9% | +134.4% | +159.3% |
| YTD | +178.2% | +22.1% | +156.2% | +177.0% |
| 1Y | +255.3% | +30.8% | +224.5% | +294.5% |
| All | +255.3% | +32.3% | +223.0% | +294.5% |
Cumulative growth
Daily Returns
Daily percentage return beside CVS.
Daily Out/Under-Performance
Portfolio return minus CVS return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CVS return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded CVS wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling